Cancer is served typical life-threatening disease with common risk factors. Developing therapeutic measures for cancers has aroused attention for a long time. However, the problems with conventional treatments are in challenge, including side effects, economic burdens, and patient compliance. It is essential to secure safe and efficient therapeutic methods to overcome these issues. The current review portrays the functions of Tanduliya (Amaranthus spinosus Linn.), and its phytoconstituents against several types of cancers, and explores the possibility of developing these agents as a promising candidate for cancer treatment. A. spinosus is an edible plant, belonging to the family Amaranthaceae widely found in Asian countries like India, Sri Lanka, Japan, and Indonesia, and used for dietary and medicinal values. Among the various beneficial pharmacological effects of A. spinosus, anticancer activity is presumably less studied. A. spinosus contains several secondary metabolites like glycosides, phenolic compounds, steroids, terpenoids, saponin, carotenoids, tannins, etc. that strongly assure their anticancer activity. The effects of A. spinosus and its various derived phytoconstituents have been shown to anticancer activity against breast, hepatocellular, prostate, and colorectal cancer in various preclinical models. The in-depth review of existing studies has shown the promising anticancer activity of A. spinosus extract, and its bioactive molecules by inhibiting the different stages of cancer, including initiation, promotion, and progression. Besides valuable nutraceuticals, A. spinosus has multi-targeted actions like antioxidant, anti-inflammatory, immunomodulatory activity and the nontoxic nature of A. spinosus probably plays a crucial role in killing cancerous cells.
Primary Language | English |
---|---|
Subjects | Pharmacognosy |
Journal Section | Review Articles |
Authors | |
Early Pub Date | August 22, 2023 |
Publication Date | December 25, 2023 |
Published in Issue | Year 2023 Volume: 6 Issue: 2 |
-------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------
CUPMAP Journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
-----------------------------------------------------------------------------------------------------------------------------------------
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.